A Randomized Phase II Prevention Trial in Subjects at High Risk for Hormone Non-responsive Breast Cancer.
Phase of Trial: Phase II
Latest Information Update: 17 Jun 2014
At a glance
- Drugs Nimesulide (Primary) ; Simvastatin (Primary)
- Indications Early breast cancer
- Focus Biomarker; Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 10 Apr 2013 Cardiovascular and inflammatory biomarker analysis presented at the 104th Annual Meeting of the American Association for Cancer Research.
- 31 Dec 2011 New trial record